What does the EAU recommend for treatment of muscle-invasive bladder cancer?

Updated: Feb 23, 2021
  • Author: Kara N Babaian, MD, FACS; Chief Editor: Bradley Fields Schwartz, DO, FACS  more...
  • Print

The EAU notes that radical cystectomy has traditionally been recommended for patients with muscle-invasive bladder cancer (MIBC), T2-T4a, N0-Nx, M0. [144] Other indications include the following:

  • High-risk and recurrent non–muscle-invasive tumors
  • T1G3 tumors that are unresponsive or refractory to BCG, or that relapse after BCG therapy
  • Extensive papillary disease that cannot be controlled with TURBT and intravesical therapy alone

Other EAU recommendations for muscle-invasive disease are as follows [144] :

  • Base the decision on bladder-sparing treatment or radical cystectomy in elderly/frail patients with invasive bladder cancer on tumor stage and comorbidity.
  • Assess comorbidity by a validated score, such as the Charlson Comorbidity Index. The American Society of Anesthesiologists score should not be used in this setting

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!